Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results.

Kayaaslan, Bircan; Oktay, Zeynep; Hasanoglu, Imran; Kalem, Ayse Kaya; Eser, Fatma; Ayhan, Muge; Guner, Rahmet

Kayaaslan, Bircan; Oktay, Zeynep; Hasanoglu, Imran; Kalem, Ayse Kaya; Eser, Fatma; Ayhan, Muge; Guner, Rahmet.

Afiliação

Kayaaslan B; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey. drbican@gmail.com.
Oktay Z; Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
Hasanoglu I; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.
Kalem AK; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.
Eser F; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.
Ayhan M; Department of Infectious Disease and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.
Guner R; Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Bilkent Street no:1, Ankara, 06800, Turkey.

Eur J Clin Microbiol Infect Dis ; 41(3): 421-430, 2022 Mar.

Article em En | MEDLINE | ID: mdl-34977996

Assuntos

Infecções por Escherichia coli; Infecções por Klebsiella; Pielonefrite; Adulto; Antibacterianos/uso terapêutico; Escherichia coli; Infecções por Escherichia coli/tratamento farmacológico; Infecções por Escherichia coli/epidemiologia; Humanos; Infecções por Klebsiella/tratamento farmacológico; Infecções por Klebsiella/epidemiologia; Klebsiella pneumoniae; Testes de Sensibilidade Microbiana; Pielonefrite/tratamento farmacológico; Pielonefrite/epidemiologia; beta-Lactamases

Palavras-chave

Acute pyelonephritis; Antibacterial drug resistance; Appropriateness of therapy; E. coli; Extended-spectrum beta-lactamase (ESBL); Urinary tract infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pielonefrite / Infecções por Klebsiella / Infecções por Escherichia coli Tipo de estudo: Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google